Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean Grimm

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Neuro-Oncology|May 17, 2017
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomasPriya Kumthekar, Sean Grimm, James Chandler, et al.
Integrative Cancer Science and Therapeutics|October 1, 2020
Prognosis of older patients with low-grade glioma: A retrospective studyPriya Kumthekar, Vaibhav Patel, Carly Bridge, et al.
Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
Journal of Neuro-Oncology|October 24, 2021
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomasKaran S Dixit, Sean Sachdev, Christina Amidei, et al.
Neuro-Oncology|November 12, 2019
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomasMichael R Drumm, Karan S Dixit, Sean Grimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcomePatrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Research Square|October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Neuro-Oncology|May 17, 2017
A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomasPriya Kumthekar, Sean Grimm, James Chandler, et al.
Integrative Cancer Science and Therapeutics|October 1, 2020
Prognosis of older patients with low-grade glioma: A retrospective studyPriya Kumthekar, Vaibhav Patel, Carly Bridge, et al.
Cancer|July 29, 2010
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomasJeffrey J Raizer, Sean Grimm, Marc C Chamberlain, et al.
Journal of Neuro-Oncology|October 24, 2021
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomasKaran S Dixit, Sean Sachdev, Christina Amidei, et al.
Neuro-Oncology|November 12, 2019
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomasMichael R Drumm, Karan S Dixit, Sean Grimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 9, 2013
Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcomePatrick G Morris, Denise D Correa, Joachim Yahalom, et al.
Research Square|October 3, 2025
Newly diagnosed glioblastoma IDHwt patients treated with radiation, nivolumab, and BMS-986205Derek Wainwright, Rimas Lukas, Lijie Zhai, et al.
Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
Pageof 2